AE Wealth Management’s Novartis NVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$882K Buy
7,289
+580
+9% +$70.2K 0.01% 760
2025
Q1
$748K Buy
6,709
+488
+8% +$54.4K 0.01% 796
2024
Q4
$605K Buy
6,221
+126
+2% +$12.3K 0.01% 847
2024
Q3
$701K Sell
6,095
-221
-3% -$25.4K 0.01% 797
2024
Q2
$672K Buy
6,316
+656
+12% +$69.8K 0.01% 801
2024
Q1
$548K Sell
5,660
-15,681
-73% -$1.52M 0.01% 795
2023
Q4
$2.29M Sell
21,341
-325
-2% -$34.8K 0.01% 856
2023
Q3
$2.21M Sell
21,666
-5,629
-21% -$573K 0.01% 817
2023
Q2
$2.75M Sell
27,295
-751
-3% -$75.8K 0.02% 735
2023
Q1
$2.58M Sell
28,046
-9,013
-24% -$829K 0.02% 703
2022
Q4
$3.36M Buy
37,059
+3,523
+11% +$320K 0.02% 581
2022
Q3
$2.55M Buy
33,536
+2,351
+8% +$179K 0.02% 623
2022
Q2
$2.64M Buy
31,185
+3,223
+12% +$272K 0.02% 577
2022
Q1
$2.45M Sell
27,962
-433
-2% -$38K 0.02% 647
2021
Q4
$2.48M Buy
28,395
+1,739
+7% +$152K 0.02% 631
2021
Q3
$2.18M Buy
26,656
+636
+2% +$52K 0.02% 618
2021
Q2
$2.37M Buy
26,020
+2,298
+10% +$210K 0.02% 581
2021
Q1
$2.03M Buy
23,722
+2,438
+11% +$208K 0.02% 562
2020
Q4
$2.01M Buy
21,284
+1,147
+6% +$108K 0.02% 493
2020
Q3
$1.75M Buy
20,137
+88
+0.4% +$7.65K 0.03% 467
2020
Q2
$1.75M Buy
20,049
+4,654
+30% +$406K 0.03% 443
2020
Q1
$1.27M Buy
15,395
+966
+7% +$79.6K 0.03% 420
2019
Q4
$1.37M Buy
14,429
+5,961
+70% +$564K 0.03% 456
2019
Q3
$736K Buy
8,468
+686
+9% +$59.6K 0.02% 519
2019
Q2
$711K Buy
7,782
+3,598
+86% +$329K 0.02% 495
2019
Q1
$360K Buy
4,184
+1,184
+39% +$102K 0.03% 418
2018
Q4
$231K Sell
3,000
-2,903
-49% -$224K 0.04% 409
2018
Q3
$456K Buy
5,903
+59
+1% +$4.56K 0.03% 344
2018
Q2
$396K Buy
5,844
+1,218
+26% +$82.5K 0.03% 288
2018
Q1
$335K Sell
4,626
-11
-0.2% -$797 0.03% 309
2017
Q4
$349K Sell
4,637
-254
-5% -$19.1K 0.03% 286
2017
Q3
$376K Buy
4,891
+958
+24% +$73.6K 0.03% 268
2017
Q2
$294K Sell
3,933
-7,419
-65% -$555K 0.04% 302
2017
Q1
$755K Buy
11,352
+5,014
+79% +$333K 0.14% 139
2016
Q4
$414K Buy
+6,338
New +$414K 0.17% 127